Medxy AI

Graft Choice Does Not Influence Revision ACL Reconstruction Risk in Football Players: Insights from a Swedish Nationwide Cohort

By MedXY 10/30/2026

A comprehensive nationwide cohort study reveals that autograft type is not linked to revision ACL reconstruction risk in football players, with age and pre-injury playing level being stronger predictors. Notably, quadriceps tendon grafts in women may increase contralateral ACL injury risk.

Clinical Updates Internal Medicine Nephrology

Sibeprenlimab Demonstrates Kidney Function Preservation in IgA Nephropathy: Insights from the Final Phase 3 VISIONARY Trial

By MedXY 10/30/2026

The phase 3 VISIONARY trial establishes sibeprenlimab as a promising therapy in IgA nephropathy, significantly stabilizing eGFR decline and reducing kidney-function deterioration over 24 months with a favorable safety profile.

Clinical Updates Neurology Ophthalmology

Optical Coherence Tomography as a Prognostic Biomarker in Multiple Sclerosis: Insights from the American Academy of Ophthalmology Report

By MedXY 10/30/2026

This article reviews evidence supporting OCT measurements of retinal layers as biomarkers for predicting multiple sclerosis progression and highlights the need for further research to enhance clinical application.

Clinical Updates Otorhinolaryngology Pediatrics

Predicting Surgical Success in Pediatric Obstructive Sleep Apnea: Insights from Weighted Analysis of Tonsillectomy Outcomes

By MedXY 10/30/2026

This study identifies preoperative apnea-hypopnea index as a key predictor of tonsillectomy success in children with obstructive sleep apnea, highlighting that surgery alone may be insufficient for severe cases.

Clinical Updates General Surgery

Multimodal Prediction in Robotic Surgery: Evaluating the Added Value of Task-Level Kinematic Metrics

By MedXY 10/30/2026

This review synthesizes evidence on the incremental predictive value of task-specific kinematic performance data combined with preoperative clinical variables for robotic surgery outcomes and surgeon experience prediction.

Clinical Updates OB/GYN & Women's Health

IVF Surpasses Surgery for Infertility in Deep and Ovarian Endometriosis: Insights from a Partially Randomized Patient Preference Trial

By MedXY 10/30/2026

This trial reveals that IVF significantly improves live birth rates compared to surgery in women with ultrasound-diagnosed deep or ovarian endometriosis-related infertility.

Clinical Updates Gastroenterology

Unveiling the Microbiota-Taurine Axis: Alginate Fiber’s Role in Promoting Mucosal Healing in Colitis

By MedXY 10/30/2026

This article explores how dietary alginate fiber enhances mucosal healing through a microbiota-driven taurine pathway, evidenced by preclinical models and translational clinical insights in ulcerative colitis.

Clinical Updates Gastroenterology Neurology

Elevated Risk of Inflammatory Bowel Disease Following Anti-CD20 Therapy in Multiple Sclerosis Patients: Insights from a Swedish Population-Based Cohort

By MedXY 10/30/2026

A Swedish cohort study reveals increased risk of inflammatory bowel disease in relapsing-remitting multiple sclerosis patients treated with rituximab compared to other therapies and the general population, underscoring the need for gastrointestinal vigilance during anti-CD20 treatment.

Clinical Updates Diabetes & Endocrinology OB/GYN & Women's Health

Reevaluating the Safety and Clinical Implications of Menopausal Hormone Therapy: A Contemporary Perspective

By MedXY 10/30/2026

Menopausal hormone therapy remains the most effective treatment for estrogen deficiency symptoms, with a favorable benefit-risk profile when individualized by age, timing, and formulation. Emerging evidence refines safety perceptions, guiding tailored clinical decisions.

Cardiology Clinical Updates Public Health

Micro- and Nano-Plastics in Coronary Circulation: Unveiling Their Role in Ischemic Heart Disease and Air Pollution Exposure

By MedXY 10/30/2026

This article evaluates the presence of micro- and nano-plastics in coronary blood of patients with ischemic heart disease, linking their burden to acute coronary events, air pollution exposure, and inflammation, highlighting a novel environmental risk factor for cardiovascular disease.

Clinical Updates Orthopedics

Return to Sport After ACL Reconstruction: Insights from a Nationwide Swedish Cohort of High-Activity Athletes

By MedXY 10/30/2026

A Swedish registry-based study reveals that 62% of athletes with high preinjury activity levels return to similar sports within a year after ACL reconstruction, with factors such as sex, age, and psychological readiness affecting outcomes.

Clinical Updates Neurology Orthopedics

Characterizing Quality of Life Profiles in Rehabilitation Patients Across Diagnoses: Insights from Latent Profile Analysis

By MedXY 10/30/2026

A cross-sectional study used latent profile analysis to identify distinct quality of life outcome profiles in rehabilitation patients with traumatic brain injury, spinal cord injury, stroke, and limb injuries, highlighting heterogeneous patient needs beyond clinical diagnosis.

Clinical Updates Pediatrics Public Health

Prenatal Exposure to Phthalates and Bisphenols and Its Association with Hypomineralization of Second Primary Molars in Children

By MedXY 10/30/2026

This study examines how prenatal exposure to endocrine-disrupting chemicals like phthalates and bisphenol A correlates with hypomineralized second primary molars (HSPM) in children, revealing sex-specific effects and emphasizing the impact of early-life chemical mixtures on dental development.

Allergy & Immunology Clinical Updates Nephrology

Povetacicept Shows Promising Interim Results in Phase 3 Trial for IgA Nephropathy

By MedXY 10/30/2026

Interim analysis of a phase 3 trial demonstrates povetacicept's efficacy in reducing proteinuria and pathological markers in IgA nephropathy, with a favorable safety profile.

Cardiology Clinical Updates

Sirolimus-Coated Balloon Angioplasty in Femoropopliteal Artery Disease Without Tissue Loss: Promising Secondary Outcomes from the SirPAD Trial

By MedXY 10/30/2026

This secondary analysis of the SirPAD trial shows that sirolimus-coated balloon angioplasty significantly reduces 1-year target-lesion revascularization rates compared to uncoated balloons in femoropopliteal artery disease patients without tissue loss, suggesting a safer and more effective treatment option.

Clinical Updates OB/GYN & Women's Health Oncology

Rilvegostomig Plus Trastuzumab-Deruxtecan: A Promising Neoadjuvant Therapy in Early-Stage ERBB2-Negative Breast Cancer

By MedXY 10/30/2026

The I-SPY2.2 trial evaluated rilvegostomig combined with trastuzumab-deruxtecan in high-risk ERBB2-negative early breast cancer, showing promising pathologic complete response rates in immune-positive tumors while reducing exposure to anthracycline chemotherapy.

Clinical Updates Orthopedics

Association of Posterolateral ACL Bundle Position with Osteochondritis Dissecans of the Lateral Femoral Condyle: A New Anatomical Insight

By MedXY 10/30/2026

This study identifies a distinct, more horizontal posterolateral ACL bundle orientation associated with osteochondritis dissecans in the lateral femoral condyle, suggesting a potential anatomical factor influencing lesion pathogenesis and healing prognosis.

Clinical Updates Neurology Rehabilitation Medicine

Enhancing Post-Stroke Dysphagia Rehabilitation: Impact of Bimodal Signal Biofeedback on the Supraglottic Swallowing Maneuver

By MedXY 10/30/2026

A randomized controlled trial demonstrates that bimodal biofeedback using accelerometer and nasal airflow sensors significantly improves swallowing function in post-stroke dysphagia patients undergoing supraglottic swallowing training.

Clinical Updates Dentistry Pathology & Lab Medicine

Dynamic Changes in Salivary Extracellular Vesicles Post Non-Surgical Periodontal Therapy: A Novel Window into Periodontitis Treatment Response

By MedXY 10/30/2026

This study reveals that six months of non-surgical periodontal therapy significantly modulates host and microbial extracellular vesicles in saliva, highlighting their potential as non-invasive biomarkers for monitoring periodontitis treatment.

Clinical Updates Nephrology

Ravulizumab in IgA Nephropathy: Interim Phase 3 Trial Analysis and Translational Insights

By MedXY 10/30/2026

Ravulizumab, a terminal complement C5 inhibitor, significantly reduces proteinuria in adults with IgA nephropathy, demonstrating safety and biomarker improvements in phase 2 and 3 trials, highlighting its therapeutic potential.